Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-007415

Options or other derivatives

  • Chief Medical Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sachs Jessica Chief Medical Officer 2024-01-23 Grant or award · Stock Option (Right to Buy) +300,000 300,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…